Boston Scientific (BSX) Guidance Cut Due to Cyberattack Impact

Boston Scientific Corporation (NYSE: BSX) experienced a 2.3% decline in trading on September 8, 2026, following a cyberattack on August 25 that disrupted manufacturing and shipping. The company announced it is unlikely to meet its previously provided guidance for third-quarter and full-year net sales and adjusted earnings per share for 2026. While operations have resumed, the cyberattack’s effects are anticipated to impact the company's financial performance. This situation highlights operational vulnerabilities that investors might not have fully considered, creating caution regarding future earnings expectations.